FindTrial
Sign In

A study to explore lymph metastases and patient prognoses of the patients with thoracic T1-T3 esophageal cancer

A multi-centre real-world observational study to explore lymph metastases and patient prognoses in thoracic T1-T3 patients with esophageal cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800014803
Enrollment
Unknown
Registered
2018-02-07
Start date
2018-02-07
Completion date
Unknown
Last updated
2018-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal cancer

Interventions

Cancer treatments:Cancer treatments

Sponsors

Henan Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: All the patients who met all of the following inclusion criteria will be included in the study: 1. Patients with age >= 18 years; 2. Patients with radical dissection of esophageal cancer; 3. Diagnosed Patients with thoracic T1-T3 esophageal cancer after surgeries.

Exclusion criteria

Exclusion criteria: All the patients who met any one of the following exclusion criteria will be excluded from the study: 1. Patients who previously received upper gastrointestinal surgery; 2. Patients with second primary tumors.

Design outcomes

Primary

MeasureTime frame
Number of patients with lymph metastases;—

Secondary

MeasureTime frame
Percentage of patients with lymph metastases;—

Countries

China

Contacts

Public ContactYin Li

He'nan Cancer Hospital

liyin825@aliyun.com+86 13903838752

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026